CD274 and cancer: Programmed death ligand-1 (PD-L1) expressed in the TME is known to be an important molecule for effector T-cell suppression and PD-L1 in cancer cells, and stromal cells interact with programmed death-1 (PD-1) in effector T-cells, which results in the suppression of cancer immunity [3,4].